U want facts
big funds buying big 480 million cash 200 million revolver Ac receivables 200 million 60 new launches Revenue close to 900 million$ Adjusted ebidita 520 million to 550 million Market cap 200 million ( trading like bankrupt or one drug company) when they have 200 + drugs 40 million float, 11 million short..10 million funds owned and another 12 million in institutions. No liquidity issues for 18 months New ceo on the horizon Photofrin could become a 100 million drug Amco growing at 8% per quarter over last year hence cinven payment. Additional growth from new launched and small acquisitions. I think next year they get back to 1 billion revenue by investing wisely.